David A. Spellman's Insider Trades & SAST Disclosures

David A. Spellman's most recent trade in Akebia Therapeutics Inc. was a trade of 63,567 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on May 16, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 1.07 per share. 16 May 2023 63,567 446,483 (0%) 0% 1.1 67,890 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 0.88 per share. 01 Mar 2023 6,400 510,860 (0%) 0% 0.9 5,616 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 0.88 per share. 01 Mar 2023 810 510,050 (0%) 0% 0.9 711 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 0.81 per share. 27 Feb 2023 7,539 517,260 (0%) 0% 0.8 6,131 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 294,300 294,300 - - Stock Option (Right to buy)
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 196,200 524,799 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 200,000 200,000 - - Stock Option (Right to buy)
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 200,000 328,599 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2022 225,000 225,000 - - Employee Stock Option (Right to buy)
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2022 60,000 129,402 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 2.15 per share. 28 Feb 2022 7,400 69,402 (0%) 0% 2.2 15,946 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 2.17 per share. 28 Feb 2022 803 128,599 (0%) 0% 2.2 1,743 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 200,000 200,000 - - Employee Stock Option (Right to Buy)
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Sale of securities on an exchange or to another person at price $ 3.40 per share. 01 Apr 2021 790 76,802 (0%) 0% 3.4 2,686 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 7,592 77,592 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 120,000 120,000 - - Employee Stock Option (Right to buy)
Akebia Therapeutics Inc.
David A. Spellman SVP, CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 70,000 70,000 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades